L
Lepu Biopharma Co Ltd
HKEX:2157
Lepu Biopharma Co Ltd
HKEX:2157
Price:
5.6
HKD
8.74%
Market Cap:
HK$10.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lepu Biopharma Co Ltd
HKEX:2157
|
CN |
|
United Malt Group Ltd
ASX:UMG
|
AU |
|
AVG Logistics Ltd
NSE:AVG
|
IN |
|
H
|
Hemang Resources Ltd
BSE:531178
|
IN |
Income Statement
Earnings Waterfall
Lepu Biopharma Co Ltd
Lepu Biopharma Co Ltd
Income Statement
Lepu Biopharma Co Ltd
Lepu Biopharma Co Ltd
Currency: CNY
| Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Interest Expense |
7
|
12
|
15
|
15
|
22
|
0
|
|
| Revenue |
16
N/A
|
169
+986%
|
225
+33%
|
205
-9%
|
368
+79%
|
700
+90%
|
|
| Gross Profit | |||||||
| Cost of Revenue |
(2)
|
(8)
|
(28)
|
(44)
|
(75)
|
(81)
|
|
| Gross Profit |
14
N/A
|
161
+1 089%
|
197
+22%
|
162
-18%
|
293
+81%
|
619
+111%
|
|
| Operating Income | |||||||
| Operating Expenses |
(719)
|
(613)
|
(413)
|
(223)
|
(684)
|
(784)
|
|
| Selling, General & Administrative |
(124)
|
(109)
|
(122)
|
(152)
|
(238)
|
(316)
|
|
| Research & Development |
(463)
|
(525)
|
(383)
|
(443)
|
(438)
|
(423)
|
|
| Depreciation & Amortization |
(78)
|
0
|
(84)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(54)
|
21
|
176
|
372
|
(8)
|
(44)
|
|
| Operating Income |
(705)
N/A
|
(452)
+36%
|
(216)
+52%
|
(61)
+72%
|
(391)
-538%
|
(165)
+58%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
6
|
(40)
|
187
|
(23)
|
(32)
|
(33)
|
|
| Non-Reccuring Items |
1
|
0
|
0
|
0
|
0
|
1
|
|
| Total Other Income |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
(699)
N/A
|
(493)
+30%
|
(30)
+94%
|
(85)
-182%
|
(424)
-397%
|
(198)
+53%
|
|
| Net Income | |||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(699)
|
(493)
|
(30)
|
(85)
|
(424)
|
(198)
|
|
| Income to Minority Interest |
10
|
6
|
8
|
13
|
13
|
21
|
|
| Net Income (Common) |
(689)
N/A
|
(487)
+29%
|
(22)
+95%
|
(73)
-229%
|
(411)
-466%
|
(177)
+57%
|
|
| EPS (Diluted) |
-0.42
N/A
|
-0.29
+31%
|
-0.01
+97%
|
-0.04
-300%
|
-0.24
-500%
|
-0.1
+58%
|
|
Switch to:
Switch to:
See Also
Discover More
